je.st
news
Zalviso New Drug Application Accepted For Filing By FDA
2013-12-04 06:04:33| drugdiscoveryonline News Articles
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that the Zalviso™ New Drug Application (NDA) was accepted for filing by the FDA onNovember 26, 2013
Tags: application
accepted
drug
filing
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||